BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Medilink Midlands - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://staging.medilinkmidlands.com
X-WR-CALDESC:Events for Medilink Midlands
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20230414T080000
DTEND;TZID=Europe/London:20230414T100000
DTSTAMP:20260413T142938
CREATED:20230406T100758Z
LAST-MODIFIED:20230406T100758Z
UID:23029-1681459200-1681466400@staging.medilinkmidlands.com
SUMMARY:IN-PERSON EVENT: The King's Awards for Enterprise event for Wolverhampton businesses
DESCRIPTION:The King’s Awards for Enterprise are a prestigious set of awards given annually to UK-based businesses that demonstrate exceptional achievement in areas such as innovation\, international trade\, sustainable development and promoting opportunity through social mobility. \nHear direct from Wolverhampton Deputy Lieutenant Professor Martin Levermore MBE and Deputy Lieutenant John Wood\, who will outline the process involved and answer any questions you may have. \nCLICK HERE TO BOOK YOUR PLACE\nWinning a King’s Award is widely considered to be a hallmark of business excellence and can bring numerous benefits to your business: \n\nIncreased brand recognition and credibility\nImproved marketing opportunities\nNetworking opportunities\nAccess to funding and grants\nImproved employee morale\n\nThe awards are valid for 5 years. Winners have reported benefiting from worldwide recognition\, increased commercial value\, greater press coverage and a boost to staff morale. Hear from previous Queen’s Awards winners sharing their experience. \nThose who gain an award will be: \n\nInvited to a Royal reception\nPresented with the award at your company by one of The King’s representatives\, a Lord-Lieutenant\nAble to fly The King’s Awards flag at your main office\, and use the emblem on your marketing materials (for example\, on your packaging\, advertisements\, stationery and website)\nGiven a Grant of Appointment (an official certificate) and a commemorative crystal trophy\n\nThe 2024 awards will open for entries in May 2023 with a closing date early in September 2023. \nFor more information about The King’s Awards for Enterprise\, please click here.
URL:https://staging.medilinkmidlands.com/event/in-person-event-the-kings-awards-for-enterprise-event-for-wolverhampton-businesses/
LOCATION:Wolverhampton Art Gallery
CATEGORIES:Other Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20230418T093000
DTEND;TZID=Europe/London:20230418T153000
DTSTAMP:20260413T142938
CREATED:20230329T143653Z
LAST-MODIFIED:20230331T102028Z
UID:22923-1681810200-1681831800@staging.medilinkmidlands.com
SUMMARY:IN-PERSON EVENT: Empowering Women in Biotech
DESCRIPTION:Taking place on 18th April between 9.30am – 3.30pm\, this event aims to bring together likeminded individuals working in the biotech and life science sector\, and women looking to pursue a career in this industry. We will have talks from inspirational women in the industry on topics ranging from leadership and the visibility of women in biotech\, investment opportunities available\, and ways to connect with one another. \nCLICK HERE TO BOOK YOUR FREE PLACE TODAY\nAim of the Event:\n\nShare personal and professional experiences and career strategies from a woman’s perspective.\nHelp women\, wherever they are in the career paths\, realise their future goals.\nEncourage women to enter and maintain careers in Biotech.\nGenerate a wider network of professionals working in Biotech.\n\nWho is it for?\nThis is an inclusive event and all are welcome particularly:\n-Women in academia and industry who would like to network\n-Women who would like to learn about and explore the opportunities available to them \nThis event is in partnership with Bionow\, Charnwood Molecular\, Charnwood Campus\, IBioIC\, Potter Clarkson\, SynBioBeta and WiSB (Women in Synthetic Biology) \nA great opportunity for academic and industry colleagues to get together. \nFor any further information please contact mollie.nolan@bionow.co.uk
URL:https://staging.medilinkmidlands.com/event/in-person-event-empowering-women-in-biotech/
LOCATION:Charnwood Molecular
CATEGORIES:Other Event
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230425
DTEND;VALUE=DATE:20230427
DTSTAMP:20260413T142938
CREATED:20230222T122112Z
LAST-MODIFIED:20230222T122112Z
UID:22348-1682380800-1682553599@staging.medilinkmidlands.com
SUMMARY:IN-PERSON EVENT: BIOTRINITY 2023: Catalysing Growth in the Life Sciences Industry
DESCRIPTION:BioTrinity is an established\, must-attend London conference\, that catalyses growth and supports in-person engagement across the life sciences industry. \nThe event is attended by an audience of early stage and emerging life sciences R&D Companies\, investors\, big pharma\, and other valued partners throughout the life sciences ecosystem. The conference features a focused\, relevant\, and stimulating programme\, led by great speakers\, who bring their knowledge\, expertise\, and vision to the fore in exciting\, high-quality sessions. \nInteracting with new companies each year is something we believe to be a critical attribute of a successful conference and we work hard to ensure that a substantial and fresh line-up of investable opportunities and collaboration possibilities are showcased. \nCLICK HERE TO BOOK YOUR PLACE TODAY\nBioTrinity features: \n\nA dedicated ‘Scientific Track’\, featuring a focus on eight core therapy areas; Oncology\, Neuroscience\, Microbiome\, Inflammatory Diseases\, Rare Diseases\, Infectious Diseases\, Medtech and Cell & Gene Therapy. Each dedicated session will include an expert update from a key opinion leader\, followed by up to 5 showcase presentations from some of the most innovative and interesting R&D companies.\nA second ‘life sciences business’ focused presentation track\, that will feature discussions and keynotes addressing topics from finance and investment\, regulatory\, government strategy and tax.\nPre-scheduled live & in-person private partnering meetings during the two-day physical conference as well as a bonus third day of virtual only partnering.\nA sponsors exhibition area and plenty of ‘all-delegate’ networking opportunities throughout both in-person day\, which are so valuable to share knowledge and unlock future collaboration and new business opportunities.\nOption for registered delegates to revisit recorded presentations in the days following the conference.\nBioTrinity Investor Drinks Reception 24 April and BioTrinity Networking Party 25 April events open to conference delegates.\n\nFor more information click here. \n 
URL:https://staging.medilinkmidlands.com/event/in-person-event-biotrinity-2023-catalysing-growth-in-the-life-sciences-industry/
LOCATION:155 Bishopsgate\, London\, 155 Bishopsgate\, London\, London\, United Kingdom
CATEGORIES:Other Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20230425T090000
DTEND;TZID=Europe/London:20230425T153000
DTSTAMP:20260413T142938
CREATED:20230222T121747Z
LAST-MODIFIED:20230302T120218Z
UID:22378-1682413200-1682436600@staging.medilinkmidlands.com
SUMMARY:IN-PERSON EVENT: Driving Innovation in Midlands Healthcare
DESCRIPTION:                                                                                        \nA Charnwood Campus NHS and Academia Collaboration Platform event\, part of a series of events and workshops to support the growth and success of the life science organisations clustered around Charnwood Campus Science\, Innovation and Technology Park. \nCLICK HERE TO BOOK YOUR FREE PLACE TODAY\nAre you developing a new healthcare product\, drug or biomarker? \nAre you interested in these therapeutic areas? \n\nRespiratory\nCancer\nDiabetes and Lifestyle\nCardiovascular\n\nAre you looking for a clinical or academic partner? \nAre you looking for new research to commercialise? \nAre you considering a Precision Medicine approach for your product? \nWould you like to have 1-2-1 discussions with world leading clinical and academic experts? \nWould you like to develop collaborative projects to de-risk new product development? \nOur event aims to grow and develop research partnerships between Industry and the University of Leicester. To facilitate this\, pump-prime funding of up to £5K per project will initially be available to help early-stage project development with potential partners following on from this event. \nFor further information on the funding available and how to book slots with the speakers\, please contact Dr Lynne Howells at lh28@le.ac.uk or iph@le.ac.uk \n\nAgenda\n9.00 – 9.20 Registration Refreshments and Poster Exhibition.  \n9.20 – 10.10 Event Welcome and Introduction to the Institute of Precision Health/Clinical Translation of Respiratory Research.  \nProfessor Chris Brightling\, Co-Director University of Leicester Institute for Precision Health\, Honorary Consultant Respiratory Physician\, Respiratory Theme Lead for Leicester NIHR Biomedical Research Centre (Respiratory). \n10.10 – 10.30 Developing the Liquid Biopsy for Cancer Diagnostics. \nProfessor Jacqui Shaw\, Co-Director University of Leicester Institute for Precision Health\, Head of Department Genetics and Genome Biology (Genetics). \n10.30 – 10.50 Clinical evaluation and enhancing uptake of MedTech to improve outcomes in diabetes.  \nProfessor Pratik Choudhary\, Honorary consultant in Diabetes\, Leicester Diabetes Centre. Chair of Diabetes Technology Network UK. \n10.50 – 11.20 Refreshments and Networking Break. \nPre-book your 10-minute slot with one of our speakers. \n11.20 – 11.40 Introduction to the PROTAC pipeline. \nDr James Hodgkinson\, Associate Professor of Chemistry and Chemical Biology\, School of Chemistry. \n11.40 – 12.00 Developing Novel Biomarkers for Disease Detection.  \nProfessor Don Jones\, Co-Director University of Leicester Institute for Precision Health\, Director of van Geest MultiOMICS facility and Dr Jim Langridge\, Waters (Biomarkers). \n12.00 – 1.40 Lunch and Networking Break.  \nPre-book your 10-minute slot with one of our speakers. \n1.40 – 2.00 Industry Talk. \n2.00 – 2.30 Industry collaborations advancing novel cardiac risk prediction tools to the clinic. \nProfessor Andre Ng\, Head of Department\, Cardiovascular Sciences\, Professor of Cardiac Electrophysiology\, Consultant Cardiologist and Electrophysiologist. \n2.30 – 2.50 How Companies can Access Funded Projects. \nDr Lucy Alexander\, Head of Business Development\, Charnwood Campus. \n2.50 – 3.00 – Professor Don Jones. Session close and collaborative opportunities. \n3.00 – 3.30 Networking and speaker slots. \n  \n Speaker Profiles\n \nProfessor Chris Brightling  \nProfessor Chris Brightling’s research focusses on improving the clinical management and understanding the mechanisms of airway diseases such as asthma\, chronic coughs and COPD. He has published over 450 peer reviewed articles. Prof Brightling is a Fellow of the Academy of Medical Sciences\, National Institute for Health Research Senior Investigator\, Respiratory Theme Lead for Leicester NIHR Biomedical Research Centre\, Director Institute for Lung Health\, and Honorary Consultant Respiratory Physician. He is Coordinator of the MRC Molecular Pathology Node EMBER and Respiratory lead for the IMI 3TR and was founding Director of the European Respiratory Society Clinical Research Collaborations. \nProf Brightling is the national lead for the post-COVID consortium PHOSP-COVID and local research lead for the COVID-19 pandemic. His main research focus is on improving the clinical management and understanding the immunopathogenesis of the airway diseases asthma\, chronic cough and COPD.  He is a member of the American College of Chest Physicians’ Cough Guidelines\, the British Thoracic Society\, American Thoracic Society/European Respiratory Society Severe Asthma guidelines and is on the scientific committee for the Global INitiative for Asthma – GINA. Prof Brightling draws on his experience in research excellence and leadership to coordinate the research teams at the University of Leicester and three Leicestershire Partnership NHS Trust sites in their COVID-19 response. \n  \n \nProfessor Jacqui Shaw \nProfessor Shaw is Head of the Department of Genetics and Genome Biology\, Co-Director of the Institute for Precision Health and Professor of Translational Cancer Genetics at the University of Leicester. Her extensive expertise in innovative blood-based tests for monitoring breast and lung cancers\, known as liquid biopsies\, is highly sought after through national and international collaborations in clinical studies and trials. Professor Shaw’s research has found that breast cancer recurrence can be detected by a blood test up to two years ahead of when traditional screening techniques would be able to detect it. This highly impactful work enabled US-based genetic testing company Natera achieve the prestigious ‘Breakthrough Device’ designation from the U.S. Food and Drug Administration (FDA) in 2019 for their Signatera™ test\, which offers patients personalised cancer testing. \nProfessor Shaw’s research group’s expertise is in molecular diagnostics. This expertise was deployed during the coronavirus pandemic to establish and lead on asymptomatic screening for COVID-19 at the University of Leicester\, using a quick antigen test known as LAMP – Loop-mediated isothermal amplification. This screening programme has supported the University in the early detection of COVID-19 outbreaks on campus by detecting staff and students with asymptomatic cases who may have unknowingly spread the virus. \n  \n \nProfessor Pratik Choudhary \nProfessor Choudhary is an honorary consultant in Diabetes with a special interest in type 1 diabetes and technology. He has active clinical and research programs around education psychology and technology in type 1 diabetes. In particular\, using neuroimaging to explore mechanisms of hypoglycaemia unawareness and use of different strategies such as technology and behavioural interventions to restore awareness. \nProfessor Choudhary is currently chair of the Diabetes Technology Network-UK working to improve access to technology for diabetes through training education and advocacy. He has experience in academic and industry-funded early-phase studies evaluating novel glucose sensors and closed loop- artificial pancreas systems to help progress technologies\, and multinational randomised clinical trials (RCTs) and Real-World Evidence studies to support implementation and policy decisions that have enabled equitable access to developed technologies across the NHS. \n  \n \nDr James Hodgkinson \nResearch within the Hodgkinson Group is focused on the synthesis of novel chemical probes and compound libraries designed to study biological processes otherwise challenging by genetic approaches. We are specifically interested in developing chemical probes for Class I Histone Deacetylase (HDAC) enzymes and other protein partners that exist in Class I HDAC multiprotein complexes. Class I HDACs and their associated complexes have been implicated in diseases such as cancer and neurodegenerative disorders. Applications include using our chemical probes to investigate novel ligand-protein interactions and protein-protein interactions within HDAC complexes\, and developing heterobifunctional molecules including proteolysis targeting chimeras (PROTACs) for the targeted degradation of Class I HDACs and their associated complex partners in cancer cells. Our overall goal and vision is that our validated chemical probes will have direct applications for use by the members of chemical biology and biology communities in revealing new biology\, studying disease and ultimately aiding the discovery of new therapeutics. \n  \n \nProfessor Andre Ng \nProfessor Ng is an expert in the management of cardiac arrhythmias especially in catheter ablation and the use of mapping systems in such procedures. He has played a key role in the establishment of an active ablation programme for Atrial Fibrillation since 2002 at Glenfield Hospital and has pioneered the use of a novel robotic system in AF ablation. He has provided proctorship for new ablation technologies at many centres worldwide. He also specialises in advance device implantation including pacemakers\, implantable cardioverter defibrillators and cardiac resynchronisation therapy (CRT) devices. \nHe has translated important preclinical findings into investigations in cardiac patients with the successful development of a novel technology for sudden death risk stratification\, LifeMap\, which won numerous prizes including Medical Futures Award 2011 – Best Innovation in Diagnostics and European Heart Rhythm Association Inventors Award 2016\, resulting in several internationally granted patents. \n  \n \nProfessor Don Jones \nProfessor Jones is co-director of the Leicester van Geest Multi-OMICs Facility\, which is a world-leading centre for biomarker research. Professor Jones’ research involves discovering and implementing novel biomarkers of disease using mass spectrometry techniques\, with particular interest in the discovery of biomarkers (proteins\, metabolites and lipids) using state-of-the-art analytical techniques in combination with novel data interrogation techniques. From these projects the group are establishing targeted assays for biomarkers and working with pathology colleagues to validate and achieve clinical accreditation for assays. \nAs Co-director of Institute for Precision Health which helps coalesce precision medicine activity across the University and NHS. All this work helps to underpin the implementation of precision medicine by finding novel tools to personalise diagnosis and treatment in modern medicine. \nProfessor Jones plays an active role in the NIHR Biomedical Research Centre which allows this research to be translated into clinical use. \n  \n \nDr Lucy Alexander  \nHead of Business Development and Senior Business Development Manager of Innovation Centre\, Charnwood at Charnwood Campus. I am passionate about research translation to real world product and have been delivering research commercialisation for over 25 years. Before joining the Campus\, I led the Leicester Life Sciences Accelerator\, focused on developing commercialisation of novel medicines and technologies with start-ups and SMEs.
URL:https://staging.medilinkmidlands.com/event/driving-innovation-in-midlands-healthcare/
LOCATION:Charnwood Campus  Loughborough\, LE11 5RB\, Charnwood Campus Loughborough\, Loughborough\, LE11 5RB\, United Kingdom
CATEGORIES:Other Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20230425T090000
DTEND;TZID=Europe/London:20230426T160000
DTSTAMP:20260413T142938
CREATED:20230117T133413Z
LAST-MODIFIED:20230124T100609Z
UID:18801-1682413200-1682524800@staging.medilinkmidlands.com
SUMMARY:Making Pharmaceuticals 2023
DESCRIPTION:The leading UK Pharmaceutical Exhibition and Conference will take place in person on 25 and 26 April at the Coventry Building Society Area.  Attend to see 200+ companies exhibiting their latest products and services. network with pharmaceutical professionals and be part of the No.1 event in the UK for Pharmaceutical professional from research to finished product. \nThere will be 6 Industry Zones:\n– Cleanroom & Hygiene\n– Laboratory\n– Processing and Machinery\n– Ingredients & Raw Materials\n– Pharmaceutical Building Facilities\n– Pharmaceutical Manufacturing and Packing Zone \nFor more information or to book your stand visit www.makingpharma.com
URL:https://staging.medilinkmidlands.com/event/making-pharmaceuticals-2023/
LOCATION:Coventry Building Society Arena\, Judds Lane\, Coventry\, CV6 6GE\, United Kingdom
CATEGORIES:Other Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20230426T123000
DTEND;TZID=Europe/London:20230426T130000
DTSTAMP:20260413T142938
CREATED:20230413T091650Z
LAST-MODIFIED:20230413T092044Z
UID:23102-1682512200-1682514000@staging.medilinkmidlands.com
SUMMARY:ONLINE SESSION: How to Create a Medical Device: Turning a Digital Health App into a Software-Based Medical Device
DESCRIPTION:How do you turn a digital health app into a medical device? \nJoin this online session to gain insights from Tim Bubb\, Technical Director of IMed Consultancy. \nThis informal\, 25-minute session offers a beginner’s guide for companies and entrepreneurs who have an existing digital health app or product (or are looking to create one)\, and are interested in making it a software-based medical device in the UK. \nTopics to cover:\n·      When does a digital health product become a medical device?\n·      At what point to start thinking about medical device implications\n·      The steps people face on their way to medical device status\n·      The benefits / opportunities of qualifying your product as SaMD \nFor more details and to book your free place\, click here.
URL:https://staging.medilinkmidlands.com/event/nuom-how-to-create-a-medical-device/
LOCATION:Online
CATEGORIES:Other Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20230427T130000
DTEND;TZID=Europe/London:20230427T160000
DTSTAMP:20260413T142938
CREATED:20230406T094026Z
LAST-MODIFIED:20230406T094026Z
UID:23020-1682600400-1682611200@staging.medilinkmidlands.com
SUMMARY:TBAT Innovation Challenge 2023 - Workshop 2 - People & Recruitment
DESCRIPTION:This free-to-attend online workshop is designed to delve into the people and recruitment solutions you need to know in order to support your business growth. We will discuss problems\, challenges and highlight opportunities to reduce the effects of barriers within people and recruitment – supporting you on your journey to commercialisation and being a disrupter in the marketplace. \nIn this webinar\, we will cover: \n\nTalent and Recruitment\nThe role of a non-executive director\nEngaging and retaining your workforce\nInvestment and share incentives\nRecruiting the best people you can\n\nSpeakers include: \n\nSam Stephens – TBAT Innovation\nShakespeare Martineau – Roger Harcourt & Rhys Wyborn\nChris Hill – Vestd\nRachael Bull – Engage and Grow Central Midlands\nSimon Bucknell – EMBS\n\nThis event forms part of the wider TBAT Innovation Challenge 2023. \nCLICK HERE FOR MORE INFORMATION AND TO BOOK YOUR PLACE\nThe Innovation Challenge is brought to you by TBAT Innovation with headline sponsor Shakespeare Martineau and has been designed by our expert team to stimulate and support innovation in SMEs. It leverages the expertise of our unique partner network while seeing our partners come together to deliver four free to attend\, vibrant and informative workshops. \nOnce our final workshop has concluded in June\, the final stage of The Innovation Challenge will open. We will invite applications for businesses to submit a full business plan to be considered for our exciting prize package. \nThe winner will receive a £5\,000 cash prize and support packages from partners involved in The Innovation Challenge\, tailored to their needs. Furthermore\, two runners up will receive a free support package from partners involved in The Innovation Challenge. \nWe will be hosting a final showcase event in October 2023 to announce the winner from 10 finalists who will be invited to pitch their business plan in 3 minute presentation in front of key investors.
URL:https://staging.medilinkmidlands.com/event/tbat-innovation-challenge-2023-workshop-2-people-recruitment/
LOCATION:Online
CATEGORIES:Other Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20230427T183000
DTEND;TZID=Europe/London:20230427T213000
DTSTAMP:20260413T142938
CREATED:20230418T151315Z
LAST-MODIFIED:20230426T143618Z
UID:23116-1682620200-1682631000@staging.medilinkmidlands.com
SUMMARY:IN-PERSON EVENT: Blüm Connect Launch
DESCRIPTION:Dear friends and colleagues\, \nWe are excited to invite you to join us at the launch of Blüm Connect™\, our industry-disrupting solution that’s set to revolutionise the healthcare sector. For a long time at Blüm HQ\, we have recognised the pressing need for high-quality yet efficient digital health innovation\, and Blüm Connect is our response to this challenge. \nJoin us for an evening of networking\, refreshments and some amazing guest speakers including Rachel Murphy and David Plumb who will share their experiences of the digital health ecosystem. We will also hear from the Blüm Team about Blüm Connect – our solution that is providing NHS Trusts\, Universities\, and allied sectors with pre-built software features\, regulatory-compliant APIs\, and full code integrations. \nCLICK HERE TO BOOK YOUR FREE PLACE TODAY\nOur event is being hosted by Tech Canal\, an organisation that supports NHS adoption and sales capabilities by creating mutually beneficial partnerships to provide better outcomes\, and transform the delivery of health and care. Tech Canal plays a crucial role in closing the loop on our rapid innovation model\, making it easier for healthcare providers to adopt our solution. \nWe highly recommend registering early as space is limited. Please reserve your place here\, and join us as we collaboratively discover the future of healthcare innovation. We welcome you to also invite a technical lead / CTO colleague of your choice. \nOn behalf of the Blüm and Tech Canal Team.
URL:https://staging.medilinkmidlands.com/event/blum-connect-launch/
LOCATION:St Ethelburga’s Centre for Reconciliation and Peace Venue\, St Ethelburga's Centre for Reconciliation and Peace Venue 78 Bishopsgate London EC2N 4AG\, London\, EC2N 4AG\, United Kingdom
CATEGORIES:Other Event
END:VEVENT
END:VCALENDAR